top of page
Scientists' Corner
The MYT1L Project Foundation's scientific advisors explain important concepts in plain and easy-to-understand language.
De Novo, Nonsense and Missense Mutations in MYT1L Syndrome
Dr. Joe Dougherty, Professor of Genetics and Psychiatry at Washington University School of Medicine, describes the two most common types of MYT1L mutations and what we know (and do not yet know) about each.
ASO (Antisense Oligonucleotide) Therapy for MYT1L Syndrome
In this video, Dr. Dougherty describes what ASOs are, how they work, and their potential to treat MYT1L Syndrome.
bottom of page